Ipamorelin 5mg

Description

Ipamorelin Peptide Overview

Ipamorelin is a synthetic pentapeptide and one of the most selective growth-hormone secretagogues studied in research. It acts as a ghrelin-receptor (GHS-R) agonist and is valued in the literature for stimulating growth-hormone release with minimal impact on other hormones.

Selective Growth-Hormone Release

Ipamorelin binds the ghrelin/growth-hormone-secretagogue receptor on the pituitary and is studied for triggering a clean, pulsatile release of endogenous growth hormone in research models.

Minimal Effect on Cortisol and Prolactin

A defining feature in the research literature is ipamorelin’s selectivity: unlike earlier secretagogues, it is studied for stimulating growth hormone without meaningfully raising cortisol or prolactin.

Supports Recovery and Metabolic Research

Through its growth-hormone axis activity, ipamorelin is investigated in models of tissue recovery, lean-mass regulation and metabolic function.

Specifications

• CAS Number: 170851-70-4
• Molecular Formula: C38H49N9O5
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Molar Mass: 711.85 g/mol
• Class: Growth-hormone secretagogue / ghrelin (GHS-R) agonist (pentapeptide)
• Storage: Refrigerate after reconstitution.
• Form: Lyophilized powder in a sterile glass vial.
• Purity: Minimum 99%
• Quantity: 5mg per vial
• Color: White

Important Note: This product is intended solely for in vitro laboratory research by licensed professionals. It is not approved by the FDA for human or animal use and should not be misbranded, misused, or mislabeled as a drug, food, supplement, or cosmetic.

References:

1. Raun K. et al. – Ipamorelin, the first selective growth hormone secretagogue – European Journal of Endocrinology
2. Growth-hormone secretagogue receptor (GHS-R) pharmacology – Endocrine Reviews
3. Selective GH release and ghrelin mimetics – Journal of Endocrinology